Product and Pipeline Analysis of the Global Rheumatoid Arthritis Therapeutics Market

Launch of Novel Oral Therapies to Result in Major Market Changes


RELEASE DATE
20-Nov-2014
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
NED2-01-00-00-00
SKU
LS00131-NA-MR_16972
Yes
SHARE

Product and Pipeline Analysis of the Global Rheumatoid Arthritis Therapeutics Market
Published on: 20-Nov-2014 | SKU: LS00131-NA-MR_16972

Need more details?

$3,950.00

$2,962.50 save 25 %

DownloadLink
Need more details?

This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and a forecast of their impact on the market. Drugs in the development stage are segmented by clinical trial phase as well as by drug class. The study covers profiles of late-stage investigational products close to being launched, patent expiration timelines, products in clinical development, launched product profiles, and new product launch timelines.

Key Findings

Key Findings (continued)

Companies to Watch

Defining Healthcare Trends in the Future

Executive Summary—CEO’s Perspective

Market Overview—Definitions

Market Overview—Definitions (continued)

Market Overview—Definitions (continued)

Market Overview—Definitions (continued)

Market Overview—Definitions (continued)

Market Overview—Definitions (continued)

Market Overview—Segmentation

Market Overview—Segmentation (continued)

Market Overview—Segmentation (continued)

Rheumatoid Arthritis Global Incidence

Drivers and Restraints

Competitive Factors and Assessment

Competitive Landscape—Count of Marketed and Pipeline Products

Competitive Landscape—Marketed and Pipeline Products

Marketed Product Analysis

Marketed Product Analysis (continued)

Patent Expiration Timeline

Pipeline Analysis—Products in Clinical Development

Pipeline Analysis—Products in Clinical Development (continued)

Pipeline Analysis—Products in Clinical Development (continued)

Product Launch Timeline

Phase 3 Clinical Program—Next Product Launches

Product Dashboard—Eli Lilly’s Baricitinib

Product Dashboard—Sanofi/Regeneron’s SAR153191/REGN88

Product Dashboard—Biocad’s BCD-020

The Last Word—Three Big Predictions

The Last Word—Discussion

Legal Disclaimer

Market Engineering Methodology

Table of Acronyms Used

Table of Acronyms Used (continued)

Table of Acronyms Used (continued)

Drivers Explained

Drivers Explained (continued)

Drivers Explained (continued)

Drivers Explained (continued)

Restraints Explained

Restraints Explained (continued)

Additional Sources of Information on Rheumatoid Arthritis

Additional Sources of Information on Rheumatoid Arthritis (continued)

Learn More—Next Steps

The Frost & Sullivan Story

Value Proposition—Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related industry research

16 Sep 2026   |   North America   |   Customer Research

US Automotive Technicians’ Choice Survey, 2025

The 2025 US Automotive Technicians’ Choice study is an insightful voice-of-customer survey that highlights the tool preferences of automotive aftermarket service technicians. The survey of 400 automotive technicians across the United States used a combination of computer-assisted telephone and compu...

16 Sep 2026   |   Global   |   Market Research

Apple Performance Tracker, Q1 2026

This Frost & Sullivan tracker provides metrics on Apple's quarterly performance (for both unit sales and revenues) for iPads, iPhones, Macs, and other products, such as iPods, Apple TVs, Beats Electronics, and Apple-branded and third-party accessories. It includes historical quarterly data for all t...

15 Sep 2026   |   Global   |   Technology Research

Growth Opportunities in Workload Identity and Access Management, Non-Human Identity Security, Threat Exposure Management, and Blockchain Security

This edition of the Cyber Security Technology Opportunity Engine (TOE) showcases emerging cybersecurity innovators advancing AI-powered security, identity and access management, data security, threat exposure management, blockchain security, cyber incident response, network protection, and agentic A...

15 Sep 2026   |   South Asia, Middle East & North Africa   |   Market Research

Future of Growth and Emerging Opportunities in the Gulf Cooperation Council, 2025–2030

The GCC has entered a period of strategic economic transformation as governments accelerate diversification efforts, strengthen economic resilience, and reduce dependence on hydrocarbon revenue amid heightened geopolitical uncertainty and evolving global trade dynamics. While the implications of the...

15 Sep 2026   |   Global   |   Market Research

Vendor Profiles: Advanced Wound Care Management Market, Global, 2025

The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and a forecast of their impact on the market. Drugs in the development stage are segmented by clinical trial phase as well as by drug class. The study covers profiles of late-stage investigational products close to being launched, patent expiration timelines, products in clinical development, launched product profiles, and new product launch timelines.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Lucila Rocca
WIP Number NED2-01-00-00-00
Is Prebook No

Product and Pipeline Analysis of the Global Rheumatoid Arthritis Therapeutics Market

$3,950.00

Special Price $2,962.50 save 25 %

In stock
SKU
LS00131-NA-MR_16972